MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.
Why We Are Advocates
Rheumatology advocacy efforts are paying off in 2012.
Life, Happiness, and the Pursuit of Rheumatology
What makes rheumatologists such a happy group?
American College of Rheumatology Award Provides Researchers Time for Career Development
The ACR Research and Education Foundation (REF) initiated the ACR REF Rheumatology Investigator Award, which supports junior investigators as they are developing a project that will compete for NIH funding.
Join 125 Colleagues and Patients to Bring Rheumatology’s Message to Capitol Hill
Rheumatology professionals and patients attending the ACR’s Advocates for Arthritis conference will convene on Capitol Hill to speak with lawmakers about issues affecting the rheumatology community.
EULAR 2012: Rewards in Risk Factor Research
Investigations of infection and comorbidities offers hints to better understanding of rheumatoid arthritis.
Why Did Rheumatoid Arthritis Begin in 1800?
The connection between periodontal disease and RA.
Neutralizing IL-23 and Its Targets May Improve Ankylosing Spondylitis
Researchers have identified a unique population of entheseal resident cells that can be activated by interleukin 23 (IL-23). This finding may be key to understanding how dysregulation of IL-23 results in precise inflammation of the entheses.
Newly Discovered Molecule Modulates Cartilage Repair
Chondrocytes play an important role in cartilage repair as well as symptom relief. Research published in Science provides insights into the role of stem cell–based therapies in the promotion of chondrogenesis and cartilage repair.
Partners in Advancing Rheumatology
The REF is making great strides in advancing treatment and finding cures for rheumatic disease.
- « Previous Page
- 1
- …
- 52
- 53
- 54
- 55
- 56
- …
- 77
- Next Page »